BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saint A, Evesque L, Falk AT, Cavaglione G, Montagne L, Benezery K, Francois E. Mitomycin and 5-fluorouracil for second-line treatment of metastatic squamous cell carcinomas of the anal canal. Cancer Med 2019;8:6853-9. [PMID: 31524335 DOI: 10.1002/cam4.2558] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Truelsen CG, Serup-Hansen E, Storm KS, Havelund BM, Kronborg CS, Spindler KG. Nonplatinum-based therapy with Paclitaxel and Capecitabine for advanced squamous cell carcinomas of the anal canal: A population-based Danish anal cancer group study. Cancer Med 2021;10:3224-30. [PMID: 33960701 DOI: 10.1002/cam4.3886] [Reference Citation Analysis]
2 Saint A, Evesque L, Falk AT, Cavaglione G, Montagne L, Benezery K, Francois E. Mitomycin and 5-fluorouracil for second-line treatment of metastatic squamous cell carcinomas of the anal canal. Cancer Med 2019;8:6853-9. [PMID: 31524335 DOI: 10.1002/cam4.2558] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Saint A, Evesque L, François É. [Metastatic squamous cell carcinomas of the anal canal: Current management and prospects]. Bull Cancer 2020;107:792-9. [PMID: 32591138 DOI: 10.1016/j.bulcan.2020.04.016] [Reference Citation Analysis]
4 Koulouris A, Tsagkaris C, Nikolaou M. Real Impact of Novel Immunotherapy Drugs in Cancer. The Experience of 10 Last Years. Toxins (Basel) 2021;13:149. [PMID: 33672017 DOI: 10.3390/toxins13020149] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]